NCT04691128: Desflurane and Brain Relaxation in Craniotomy

NCT04691128
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Not yet recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years to 60 Years (Adult)
Location of Metastases: Brain
Additional Notes: Patients must be scheduled for elective craniotomy for supratentorial cerebral tumors
Exclusions: 
https://ClinicalTrials.gov/show/NCT04691128

Comments are closed.

Up ↑